These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26110613)

  • 1. Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
    Sekiguchi T; Umemura T; Fujimori N; Shibata S; Ichikawa Y; Kimura T; Joshita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
    PLoS One; 2015; 10(6):e0131658. PubMed ID: 26110613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
    Joka D; Wahl K; Moeller S; Schlue J; Vaske B; Bahr MJ; Manns MP; Schulze-Osthoff K; Bantel H
    Hepatology; 2012 Feb; 55(2):455-64. PubMed ID: 21993925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of a cell death biomarker predict the development of cirrhosis-related conditions in primary biliary cholangitis.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Nozawa Y; Ohira H
    Med Mol Morphol; 2018 Sep; 51(3):176-185. PubMed ID: 29380060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
    Umemura T; Joshita S; Sekiguchi T; Usami Y; Shibata S; Kimura T; Komatsu M; Matsumoto A; Ota M; Tanaka E
    Am J Gastroenterol; 2015 Jun; 110(6):857-64. PubMed ID: 25916223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina.
    Valva P; Rios D; Casciato P; Gadano A; Galdame O; Mullen E; Bertot G; de Matteo E; Preciado MV
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):637-644. PubMed ID: 29384795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.
    Waidmann O; Brunner F; Herrmann E; Zeuzem S; Piiper A; Kronenberger B
    Liver Int; 2016 Oct; 36(10):1464-72. PubMed ID: 26991828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A noninvasive diagnostic model of liver fibrosis using serum markers in primary biliary cirrhosis].
    Ma JL; Wang R; Zhang FK; Jia JD; Ou XJ; Zhang T; Wang Y; Duan WJ; Zhao XY; You H; Ma H
    Zhonghua Nei Ke Za Zhi; 2012 Aug; 51(8):618-22. PubMed ID: 23158860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis.
    Wang H; Xu H; Wang X; Wu R; Gao X; Jin Q; Niu J
    Medicine (Baltimore); 2016 Mar; 95(11):e3114. PubMed ID: 26986159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients.
    Zhang Y; Shi Y; Wu R; Wang X; Gao X; Niu J
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):682-686. PubMed ID: 29462025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
    Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
    Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Pimentel CF; Jiang ZG; Otsubo T; Feldbrügge L; Challies TL; Nasser I; Robson S; Afdhal N; Lai M
    Dig Dis Sci; 2016 Mar; 61(3):905-12. PubMed ID: 26462489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis.
    Poupon R
    Dig Dis; 2015; 33 Suppl 2():115-7. PubMed ID: 26642068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
    Floreani A; Cazzagon N; Martines D; Cavalletto L; Baldo V; Chemello L
    Dig Liver Dis; 2011 Nov; 43(11):887-92. PubMed ID: 21783442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.